Alcyomics® retweeted
#SOTTV presents “Alcyomics Ltd.” Gain insight on the work being done at @Alcyomics and how its approach to using a human-based system may help predict adverse immune reactions to compounds in this paid film by @WebsEdge_Med. bit.ly/3tjdVWg
Alcyomics® retweeted
Hear from Professor Anne Dickinson, Founder and CEO of @Alcyomics, who explains how their products can help support the safety profile in Cell and Gene Therapy products.
Watch ➡️ youtube.com/watch?v=BGLz3ggC…
Alcyomics® retweeted
🧬Here are many of the Northern Alliance team who met this week to celebrate the success of the project so far and plan for the future...🧬
Alcyomics® retweeted
Our recent paper in JITC describing a really fascinating case of #SJS secondary to contrast media following #ICI the therapy. Biological samples from this patient are already helping us to understand the mechanism of pathogenesis in skin blistering ADRs. teapawt.net/immunopharm/status/139…
Alcyomics® retweeted
On @ScienceWeekUK we want say how proud we are of all of the businesses and scientists that call @BiosphereNCL home - Innovating for the future and supporting people to live well. #BSW21
Alcyomics® retweeted
Replying to @nvisionabdn
Loved the realistic comparison of career progression within academia versus industry. Thanks Claire Pearce @EvOx_Ltd and Shaheda Ahmed @Alcyomics.
Alcyomics® retweeted
For International Women's Day & British Science Week 2020 we celebrated the careers of several influential women working in STEM, including @ChiOnwurah MP, Professor Ruth Plummer (@UniofNewcastle) & Dr Shaheda Ahmed (@Alcyomics)
thebiospherenewcastle.co.uk/… #WomenInSTEM
Alcyomics® retweeted
Theres still time to apply for this exciting PhD studentship working in my group in collaboration with @ImmunoPharm and @Alcyomics developing models of severe skin adverse drug reactions. happy to chat with anyone interested
([email protected]). findaphd.com/search/ProjectD…
Alcyomics® retweeted
Planning on applying for a PhD to start in 2021?
@The_MRC funded project with DiMeN:
Use of 3D skin models to elucidate the molecular pathogenesis of epidermal detachment in severe drug-induced skin reactions
Liverpool: Dr Dan Carr & iCASE @Alcyomics
findaphd.com/search/ProjectD…
Alcyomics® retweeted
Exciting @DiMeN_DTP funded PhD opportunity in my group working with @ImmunoPharm at @LivUniISMIB @LivUni and @Alcyomics developing in vitro models of severe skin adverse drug reactions. findaphd.com/search/ProjectD…
Alcyomics® retweeted
We’re delighted that our partner @Alcyomics has been successful in its bid for a Fast Start grant of £50,000 from @innovateuk to undertake critical scientific support to aid in the development of a vaccine for #COVID19. Read more ⬇️
theattcnetwork.co.uk/news/al…
Alcyomics® retweeted
Learn how leading biopharmaceutical companies can streamline antibody discovery and cell line development with Cyto-Mine: hubs.ly/H0r475r0
#biologics #drugdiscovery #microfluidics
Alcyomics® retweeted
Hear about the challenges in designing #ATMP clinical trials with small patient populations, reimbursement uncertainty, & long term prospects for the commercialisation of #advancedtherapies at the below webinar on 18 June @CGTCatapult @Medidata
Register➡️bit.ly/3dmu1EJ
Alcyomics® retweeted
Excellent article on how #pharmacists can ensure the safe delivery of chimeric antigen receptor T-cell therapy by ensuring governance, operational & clinical requirements are met via @PJOnline_News
Great work @AnneBlackPharm, Sumantha Gabriel & David Caulfield @NewcastleHosps
Delighted to receive my copy of the #pharmaceuticaljournal this morning and to see the CAR-T cpd article in print. Thanks to Sumi and Dave @rpharms #panuk #pwg for #atmps @NHS_SPS @naattc pharmaceutical-journal.com/c…
Alcyomics® retweeted
This #InternationalClinicalTrialsDay, we'd like to take the opportunity to say thank you to everyone who makes #research possible 🙌
#ICTD2020 #clinicaltrials #healthresearch #ATMPs #AdvancedTherapy
Alcyomics® retweeted
.@CGTCatapult links with Japan's CiRA Foundation to launch a new collaborative #research project focused on induced pluripotent stem (iPS) cell characterisation.
Read more ⬇️ via @PharmaTimes
pharmatimes.com/news/cell_an…
Alcyomics® retweeted
More than 90 vaccines are in development, at least six are already being tested for safety in people.
But the biggest challenge will be determining which vaccines actually work.
go.nature.com/2W15SgT
Alcyomics® retweeted
More than 90 vaccines are being developed against SARS-CoV-2 across the world. At least six groups have begun injecting formulations into volunteers in safety trials. Here is a graphical guide explaining each vaccine design. #COVID19 go.nature.com/3aPtzfX
Alcyomics® retweeted
We've created a toolbox to assist #NHS Trusts, clinical leads, industry and academic partners to better understand the diverse and specialised processes involved in the set-up and operational delivery of #AdvancedTherapy trials.
View the free resource at: bit.ly/3atMddF
Alcyomics® retweeted
Fab to open the #WomenInSTEM Celebration today at the brilliant @BiosphereNCL in a room packed w great women!
#WomenInSTEM #InternationalWomenDay2020





















